Drugs / Moderna
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05279365 | Jul 2021 → Aug 2022 | COVID-19 | DHR Health Institute for Research and Development | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05387317 | Apr 2024 → Jan 2025 | COVID-19 | Murdoch Childrens Research Institute | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moderna | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05387317 ↗ |
| Modality | Vaccine | “Moderna vaccine” NCT05279365 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT05279365 ↗ |